BDNF and major depressive disorder: Peripheral administration of LPS, used as an inflammatory model of depression, also results in decreased levels of BDNF in the brain [231], reduced expression of BDNF mRNA [232], and reduced BDNF protein levels in the rat hippocampus [233].